C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2695485
The present invention provides biomarkers which are predictive for the clinical benefit of EGFR inhibitor treatment in cancer patients.
La présente invention porte sur des biomarqueurs qui sont prédictifs au regard de l'avantage clinique d'un traitement par un inhibiteur d'EGFR pour des patients atteints de cancer.
Delmar Paul
Klughammer Barbara
Lutz Verena
Mcloughlin Patricia
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Predictive markers for egfr inhibitor treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Predictive markers for egfr inhibitor treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Predictive markers for egfr inhibitor treatment will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1991167